Linagliptin Add-on to Insulin Background Therapy
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- First Posted Date
- 2016-09-13
- Last Posted Date
- 2020-03-25
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 206
- Registration Number
- NCT02897349
- Locations
- 🇨🇳
Tianjin Medical University General Hospital, Tianjin, China
🇨🇳The General Hospital of Chinese People's Armed Police Forces, Beijing, China
🇨🇳Shengjing Hospital of China Medical University, Shengyang, China
Single Rising Dose Study of BI 690517 in Healthy Volunteers
- First Posted Date
- 2016-09-07
- Last Posted Date
- 2023-06-06
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 50
- Registration Number
- NCT02891148
- Locations
- 🇩🇪
Humanpharmakologisches Zentrum Biberach, Biberach, Germany
BI 695501 Versus Humira in Patients With Active Crohn's Disease: a Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity
- First Posted Date
- 2016-08-18
- Last Posted Date
- 2020-06-04
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 147
- Registration Number
- NCT02871635
- Locations
- 🇺🇸
MGG Group Co. Inc. / Chevy Chase Clinical Research,, Chevy Chase, Maryland, United States
🇺🇸Borland-Groover Clinic, Jacksonville, Florida, United States
🇺🇸Advance Medical Research Center, Miami, Florida, United States
Post-authorisation Safety Study in Patients With Type 2 Diabetes to Assess the Risk of Liver Injury, Kidney Injury, Urinary Tract and Genital Infections, and Diabetic Ketoacidosis in Patients Treated With Empagliflozin, Compared to DPP-4 Inhibitors
- First Posted Date
- 2016-08-12
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 333580
- Registration Number
- NCT02864914
- Locations
- 🇬🇧
RTI health solutions, One Or Multiple Sites, United Kingdom
Vahelva Respimat Regulatory Post-marketing Surveillance in Korean Patients With Chronic Obstructive Pulmonary Disease
- Conditions
- Pulmonary Disease, Chronic Obstructive
- Interventions
- First Posted Date
- 2016-08-12
- Last Posted Date
- 2022-03-28
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 3223
- Registration Number
- NCT02864407
- Locations
- 🇰🇷
Chonnam National University Hospital, One Or Multiple Sites, Korea, Republic of
Transporter Cocktail Mutual Interaction
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2016-08-03
- Last Posted Date
- 2023-11-07
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 30
- Registration Number
- NCT02854527
- Locations
- 🇩🇪
Humanpharmakologisches Zentrum Biberach, Biberach, Germany
Effect of Tiotropium + Olodaterol on Breathlessness in COPD Patients
- Conditions
- Pulmonary Disease, Chronic Obstructive
- Interventions
- First Posted Date
- 2016-08-02
- Last Posted Date
- 2019-09-27
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 106
- Registration Number
- NCT02853123
- Locations
- 🇧🇪
Hasselt - PRAC Aumann, J-L, Hasselt, Belgium
🇨🇦McGill University Health Centre (MUHC), Montreal, Quebec, Canada
🇨🇦McMaster Univ. Medical Centre, Hamilton, Ontario, Canada
Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 655130 in Healthy Male Volunteers
- Conditions
- Healthy
- Interventions
- Drug: BI 655130 (spesolimab)Drug: Placebo
- First Posted Date
- 2016-08-02
- Last Posted Date
- 2024-03-18
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 40
- Registration Number
- NCT02852824
- Locations
- 🇧🇪
SGS Life Science Services - Clinical Research, Edegem, Belgium
Influence of Fluvoxamine on the Pharmacokinetics of BI 409306
- Conditions
- Healthy
- Interventions
- Drug: BI 409306 - Powder for oral solution (PfOS)Drug: BI 409306 - film coated tablet
- First Posted Date
- 2016-08-02
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 18
- Registration Number
- NCT02853136
- Locations
- 🇩🇪
Humanpharmakologisches Zentrum Biberach, Biberach, Germany
Long-term Use of Spiolto Respimat in Japanese Patients With Chronic Obstructive Pulmonary Disease
- First Posted Date
- 2016-08-01
- Last Posted Date
- 2019-12-06
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 1335
- Registration Number
- NCT02850978